FDA EUA Makes First N99 Filter Patch Available for Use With CPAP and BIPAP

PortPatch is made with a hydrophobic, N99-rated filter material to filter out 99% of airborne particulates through exhalation ports, anti-asphyxia valves and carbon dioxide vents on CPAP, BiPAP and other non-invasive ventilation masks.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, February 2, 2021
Information
Tags: 
Medical devices, Medical Supplies, FDA, Fitness & Nutrition, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Medicine, Clinical medicine, Medical specialties, Intensive care medicine, Respiratory therapy, Non-invasive ventilation, Medical equipment, Continuous positive airway pressure, Mechanical ventilation, Positive airway pressure
Geotags: 
United States, Tennessee
⚠ generated by AI ↴
Organisation: 
AZIMUTH SLEEP SOLUTIONS
Summary
Key Points: 
  • PortPatch is made with a hydrophobic, N99-rated filter material to filter out 99% of airborne particulates through exhalation ports, anti-asphyxia valves and carbon dioxide vents on CPAP, BiPAP and other non-invasive ventilation masks.
  • PortPatch also remained in place over vents and ports during tests of low to very high levels of airflow pressures.
  • PortPatch allows CPAP and BiPAP to be used more safely in all patient-care settings: hospitals, surgical centers, long- term care facilities, and sleep laboratories.
  • PortPatch is applied to CPAP mask ports and vents, increasing safety for health providers and providing more treatment options for patients.


Azimuth Sleep Solutions has received FDA Emergency Use Authorization(EUA) for their patent-pending PortPatch™ product, in order to expand air filtration capabilities for patient treatment options and to help keep healthcare workers safer in patient-care areas where non-invasive ventilatory treatment devices need to be used. PortPatch™ is made with a hydrophobic, N99-rated filter material to filter out 99% of airborne particulates through exhalation ports, anti-asphyxia valves and carbon dioxide vents on CPAP, BiPAP and other non-invasive ventilation masks.

Independent test data of PortPatch™ showed no retention of carbon dioxide. PortPatch™ also remained in place over vents and ports during tests of low to very high levels of airflow pressures. PortPatch™ allows CPAP and BiPAP to be used more safely in all patient-care settings: hospitals, surgical centers, long- term care facilities, and sleep laboratories. This universal, simple and inexpensive solution can be used on any design or brand of CPAP mask.

“We are excited to bring this new option to health care providers and patients around the country,” said Dr. Kristen Archbold, CEO and Co-Founder of Azimuth Sleep Solutions. “During this global pandemic we are all focused on innovative ways to increase safety for health care workers and expand treatment options for patients.”

PortPatch™ is applied to CPAP mask ports and vents, increasing safety for health providers and providing more treatment options for patients.

About Azimuth Sleep Solutions

Our Health Mission

Azimuth Sleep Solutions believe that a good night's sleep is a basic human right. Our mission is to make CPAP treatment a comfortable part of your nightly sleep routine.

Experience and Professionalism

With over 20 years of experience in care of patients with obstructive sleep apnea, our founder is an RN, has a PhD in Nursing and has conducted federally-funded research on how use of CPAP improves health for adults and children. We work closely with key opinion leaders in the field of sleep medicine and dental science to insure our products are the best available.

To learn more please visit azimuthsleepsolutions.com.

Copyright: 
Copyright Business Wire 2021